- November 7, 2013 | BY
Charles River recently aided in a study involving wild rats who, let’s face it, represent a much different “clientele” than the well-bred laboratory rats we traditionally work with on a daily basis.
- November 4, 2013 | BY
It’s been 11 years since the US National Heart Lung and Blood Institute halted a major clinical trial1 testing the risks and benefits of estrogen plus progestin.
- October 30, 2013 | BY
Long before biologists had the ability to transfer human cancer cell lines into immune-compromised mice, their approach was somewhat more basic.
- October 21, 2013 | BY
There was a time, not too long ago, when cancer was more or less unspoken. You rarely heard about someone’s diagnosis. The mere mention of the word terrified people because the disease was considered a death sentence.
Today, it’s a different scene. We have treatments that one could only have imagined 20 years ago. We’ve ...
- October 14, 2013 | BY
In the 1970s, the first of several research studies suggested a bold new approach in the fight against breast cancer.
- October 7, 2013 | BY
When President Nixon declared war on cancer in 1971, the arsenal included radiation and a handful of chemotherapy drugs. But the preferred weapon was the scalpel, not just to remove tumors but to diagnose disease.
- September 30, 2013 | BY
Challenges—and progress—in diagnosing and translating CNS disease from mouse to men
- September 23, 2013 | BY
To the dismay of millions of chronic pain sufferers, the search for novel analgesics over the past several decades hasn’t produced much relief. In fact, it’s been one big pain in the…well, you know.
- September 16, 2013 | BY
Without a doubt, animal models of disease have contributed widely to the development of new drugs for the treatment of many human diseases such as cancer, diabetes or infectious diseases.
- September 10, 2013 | BY
Hypertension, or high blood pressure, is a stealth-like condition that can wield a large and very dangerous stick.